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Abstract
Background
Although Plasmodium vivax contributes to almost half of all malaria cases outside Africa, it
has been relatively neglected compared to the more deadly P. falciparum. It is known that
P. vivax populations possess high genetic diversity, differing geographically potentially due
to different vector species, host genetics and environmental factors.
Results
We analysed the high-quality genomic data for 46 P. vivax isolates spanning 10 countries
across 4 continents. Using population genetic methods we identified hotspots of selection
pressure, including the previously reported MRP1 and DHPS genes, both putative drug
resistance loci. Extra copies and deletions in the promoter region of another drug resistance
candidate, MDR1 gene, and duplications in the Duffy binding protein gene (PvDBP) poten-
tially involved in erythrocyte invasion, were also identified. For surveillance applications,
continental-informative markers were found in putative drug resistance loci, and we show
that organellar polymorphisms could classify P. vivax populations across continents and dif-
ferentiate between Plasmodia spp.
Conclusions
This study has shown that genomic diversity that lies within and between P. vivax popula-
tions can be used to elucidate potential drug resistance and invasion mechanisms, as well
as facilitate the molecular barcoding of the parasite for surveillance applications.
Background
The Plasmodium vivax malaria parasite is the second most virulent malaria species after P. fal-
ciparum. Geographically, it is found throughout Asia, South and Central America, Oceania,
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Middle East and some parts of Africa, with nearly 2.85 billion people at risk of infection [1].
Although P. vivax contributes to almost half of all malaria cases outside Africa, as it kills infre-
quently and is not amenable to continuous in vitro culture, it has been relatively neglected
compared to the more deadly P. falciparum [2]. However, as P. vivax drug-resistant strains
emerge and spread and fatality rates increase, the need to implement better control and elimi-
nation strategies is becoming urgent. Many of the interventions used for controlling P. falci-
parum malaria are not as effective against P. vivax. Consequently, P. vivax has become the
dominant malaria parasite in several countries where P. falciparum transmission has been
successfully reduced. Hence, control and elimination of P. vivax malaria calls for additional
interventions, notably against the dormant liver stage of the parasite. However, gaps in our
knowledge of P. vivax epidemiology and biology may compromise its control. Genomic
research can contribute greatly to enhancing our understanding of P. vivax basic biology and
evolutionary history, supporting the development and surveillance of new interventions.
Since the first characterisation of the P. vivax genome sequence (Sal-1, [3]), several popula-
tion genetic studies, based on microsatellite data and more recently using whole genomes,
have shown that this parasite is more polymorphic than P. falciparum [4,5,6,7]. P. vivax popu-
lations harbour high genetic diversity, even on small spatial scales, and can differ extensively
between locations due to vector species, host genetics and environmental factors [4,5,6].
Genetic variation enables the parasite to overcome host immune responses and antimalarial
drugs to establish persistent infections and increase transmission. Genomic studies in natural
populations of P. vivax can pinpoint genetic regions that are under selective pressure, includ-
ing those associated with resistance to antimalarial drugs. Such studies can also contribute to
the identification of vaccine targets. Moreover, global genomic studies can assist with identify-
ing sets of polymorphism private to populations, allowing the monitoring of gene flow over
space and time, and the tracking of imported infections. By developing a molecular barcode of
individual parasites it will also be possible to distinguish recrudescent from re-infections.
Highly polymorphic microsatellites have been the preferred method of genetic analysis,
revealing high levels of diversity and highlighting interesting genotypic patterns and geograph-
ical clustering across global populations [8, 9, 10, 11, 12]. The advancement of whole genome
sequencing technologies has opened up opportunities to obtain a comprehensive picture of
the epidemiology and structural variation of P. vivax. There is now the ability to perform
genome-wide analysis of the various populations without the need for in vitro culture and
overcoming difficulties with low parasitaemias and high human DNA contamination [13].
Recent studies using genome-wide SNPs highlighted that signals of natural selection suggest
that P. vivax is evolving in response to antimalarial drugs and is adapting to regional differ-
ences in the human host and the mosquito vector [6,7]. Several other whole genome sequence
studies have been published [13, 14, 15, 16], covering 10 countries. Using these and other
data, we explore the genetic diversity within and between continents, identify signatures of
drug pressure and molecular barcodes that could be useful for determining the source of infec-
tions and monitoring parasite populations.
Methods
Samples and sequence data
Publicly available whole genome sequence data for 74 P. vivax samples were gathered from
multiple sources, and included reference strains (India VII, Mauritania X, North Korea II, Bra-
zil I, Sal-1 from El Salvador (see [2])), field and clinical isolates (Cambodia (n = 3) [13], Thai-
land (n = 39) [13], Madagascar (n = 3) [2,17], Colombia (n = 8) [14] and Peru (n = 11) [7,15])
and clinical samples from travellers (to Papua Indonesia (n = 2) [13], India (n = 2) [13], and
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Papua New Guinea (PNG, n = 6) [13]). All sequencing data for non-reference strains were
generated using Illumina paired end technologies (read lengths75bp). The raw sequence
data were mapped to the Sal-1 reference genome (version 10.0) using bwa-mem with default
parameters. SNPs (n = 447,232) were identified using the samtools software suite (samtools.
sourceforge.net) with high quality scores (phred score>30, 1 error per 1 kbp). Genotypes were
called using ratios of coverage, where the minimal heterozygous calls still present after filtering
were converted to the majority genotype if the coverage ratio was 80:20 or greater [18,19].
SNPs were retained if they were biallelic, had low genotype missingness (<10%) and heterozy-
gous (<0.4%) calls. SNPs in regions of extreme coverage and very low coverage were excluded,
as well as in non-unique regions (using a k-mer approach with length of 54 bp) and highly
polymorphic VIR genes. Two samples were found to have P. vivax and P. falciparum co-infec-
tions (ERR020124 and SRR828528), and were excluded from population genetic analysis. Iso-
lates were retained if they had at least average 10-fold genome-wide coverage, and at most 10%
missing genotype calls. The final high quality dataset consisted of 46 (62.2%) isolates (Thailand
22, Southeast Asia 24, South America 11; other 11; S1 Table) and 219,288 SNPs, and used as
the basis of population genetic analyses. FreeC software (http://bioinfo-out.curie.fr/projects/
freec/tutorial.html) was used to identify regions of the genome with a significant increase or
decrease in read coverage identifying potential copy number variants (CNVs) after accounting
for GC bias through coverage normalization. Regions identified as CNVs were inspected visu-
ally and assessed using de novo assembly methods [20].
Population genetics
Genetic diversity was estimated using the average pairwise nucleotide diversity (π) with the
R package "pegas". An in-house R script was used to compute the allele frequency-based Taji-
ma’s D test [21] to identify genes under balancing selection in the individual populations
(values > 2.5; [18]), this method was chosen over the dN/dS approach given the latter being
not fit for analysis on individual populations [22]. To detect signals of directional selection,
the integrated Haplotype Score (iHS) approach [23] was applied to individual populations sup-
ported by a principal component analysis (PCA). This approach used the most frequent allele
where mixed calls where found so the haplotype analysis will be based on the most abundant
strain in each sample [7]. P-values for iHS were computed from standardised values based on
a 2-tailed conversion from a Gaussian distribution [19]. The Salvador-I being the reference
and oldest sample was used as ancestral haplotype. Multiplicity of infection was estimated
using a novel method of counting the unique haplotypes formed by polymorphism on paired
sequencing reads (estMOI, [24]). For comparisons between populations, we first applied PCA
and neighbourhood joining tree clustering based on a matrix of pairwise identity by state val-
ues. These analyses were followed by applying the cross population long-range haplotype
method (XP-EHH [25], Rsb implementation [19]) and the population differentiation metric
FST [26]. P-values for the Rsb estimates were calculated using a Gaussian approximation [19].
A significance threshold of P< 0.001 was established for both iHS and Rsb using bootstrap-
and permutation-based simulation approaches [18,19]. We used the ranked FST statistics to
identify the informative polymorphism for the barcoding of populations and driving the clus-
tering observed in the PCA. Linkage disequilibrium (LD) was assessed in the two populations
with the largest sample sizes (Thailand and South America) using the r2 and D’ metrics [27],
calculated for pairs of SNPs with different physical separation up to 2 kbp using a sliding win-
dow approach. The SNPs were annotated and effects of variants on genes (such as amino
acid changes) were predicted using snpEFF software [28]. The R statistical package was used to
analyse SNP data, including implementation of selection analyses using the “rehh” library.
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Results
Genetic polymorphisms
The genomic coverage in the nuclear genome was high (median 103-fold, range (30-5973-
fold), and in keeping with multiple organellar copies, the mitochondria and apicoplast cover-
age was 30-fold and 1.8 fold greater than the nuclear coverage. The density of SNPs in the nu-
clear genome (219,288 SNPs, 1 every 99 bp) was greater than in the mitochondrial (23 SNPs, 1
every 165 bp) and apicoplast genomes (176 SNPs, 1 every 165 bp) (S2 Table). Although 60% of
the annotated reference genome is coding (chromosomal range: 54%-64%), approximately
half the SNPs in the isolates were found in genic regions (mean 48% per chromosome, range
43% to 52%) (Fig 1A). The proportion of non-synonymous sites is consistent with those found
in other Plasmodium species, with 52% of coding SNP sites being non-synonymous in the
nuclear genome, 36% in the mitochondrion and 56% in the apicoplast. The differences in
these genomes suggest they may be subject to differential selective pressure [29]. The majority
of SNPs are rare, with nearly half of the mutations (45%) being observed in single samples (Fig
1B) as seen in other Plasmodium populations [18]. There was some evidence of polyclonality
in 22 samples (Cambodia 1/2, Colombia 5/5, Madagascar 2/2, PNG 2/5, Thailand 11/22).
Analysis of structural variants and copy number variants was limited to Thai, Cambodian
and Madagascan isolates, which had high and uniform genomic coverage. CNVs were located
Fig 1. (a) SNP locations by annotation*. (b) Minor allele frequency spectrum indicates a predominance of rare alleles. (c) Linkage
disequilibrium (r2) decays rapidly with physical genetic distance. * established using snpEFF software.
https://doi.org/10.1371/journal.pone.0177134.g001
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less than 1 kbp distance from the MDR1 gene (chromosome 10, PVX_080100) in Cambodian
and Thai isolates (S1 Fig). Several MDR1 variants have previously been reported, some consid-
ered putative chloroquine- and mefloquine-resistance alleles [14,30–35]. At the MDR1 locus,
we observed either a duplication of ~35kb (position 351kbp to 389kbp, n = 1, Thailand), a
major deletion in the promoter region of the gene (n = 7, Thailand; n = 1 Cambodia), or a
combination of both structural variants, including two copies, one with the deletion in the pro-
moter and another copy with a complete promoter (n = 4, Thailand); as confirmed by the
increase or decrease in coverage and accumulation of split reads in the regions where a break
in the coverage occurs. The known duplication in the Duffy binding protein PvDBP (chr. 6:
974,000–982,000, PVX_110810) in Malagasy [36] was confirmed in one of the two Madagascan
isolates (SRR828416). The PvDBP gene is potentially involved in erythrocyte invasion, and the
duplication was also observed in thirteen Thai isolates. A further duplication was observed in
Pv-fam-e (a RAD gene, chr. 5: 895,000–900,000, n = 8, Thailand), a gene linked to P. vivax
selectivity for young erythrocytes and/or immune evasion [36].
Assessing genetic diversity, LD and positive directional selection
The average polymorphism (pair-wise mismatches measured by nucleotide diversity π) was
calculated by gene and chromosome. There was little difference across the chromosomes with
mean 11.1x10-4 (range 6.0 x 10−4 to 19.0x10-4), which is consistent with other studies with sim-
ilar sample size [14] as well as larger datasets when restricted to high quality SNPs (1.5x10-3)
[6, 7]. LD decays rapidly for non-rare polymorphism (minor allele frequency 5%) within a
few hundred base pairs, and reaches a baseline within 500bp in South American and Thai
nuclear genomes (Fig 1C). Like P. falciparum, there is a high correlation between non-rare
SNPs (median D’ 0.918, range 0.425–1) in the mitochondrial and apicoplast genomes support-
ing the inference that the organelles are co-inherited and supporting the view that these SNPs
have potential utility for barcoding [29].
To examine evidence for signatures of positive natural selection we calculated the iHS met-
ric in the Thailand and South America populations, informed by the population structure
reported in S3 Fig. Five contiguous loci of strong positive directional selection were identified,
including the MRP1 gene (PVX_097025) and its promoter region in Thailand, and a region
surrounding the MRP2 gene (PVX_097025,P. falciparum homologue associated with prima-
quine and antifolate drug sensitivity [14]). Several surface proteins were identified in both
populations, including the MSP7 and MSP3.1, which are thought to be under selection pres-
sure due to their role in erythrocyte invasion and strong vaccine candidates and have been
identified before by other studies using sanger sequencing [29] (Table 1, Table 2, S2 Fig). In
addition, some helicases showed strong signals of selection (PVX_088190 and PVX_111220)
which were also detected in the same study [36] reinforcing the method used. Furthermore,
we identified in South America a proximal region of selection (chr14: 1,414,164–1,479,586)
described elsewhere [7].
Allele frequency spectrum and balancing selection
The allele frequency spectrum of different classes of nucleotide sites all show an excess of rare
alleles, with coding, non-synonymous, synonymous and intergenic sites more skewed than
expected under a Wright-Fisher model of constant population size [18]. This observation
could indicate a population expansion in the recent past, where as a population grows in size,
the frequency of rare alleles also increases [18]. The Tajima’s D method was applied to genes
with at least five SNPs in the two main populations (Thailand 4,673 (91.0%) and South Amer-
ica 3,549 (70.0%) genes). The majority of Tajima’s D values were negative (Thailand 90.2%;
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South America 64.4%), reinforcing the presence of an excess of low frequency and singleton
polymorphisms, potentially due to population expansion in the recent past or purifying selec-
tion. For Thailand, we identified 398 (8.5%) genes with positive Tajima’s D values, of which 14
were in excess of 2.5 and potentially under balancing selection (Table 3). Similarly, for South
America, of the 1,260 (35.5%) values that were positive, 12 were in excess of 2.5 (Table 3). The
loci under potential balancing selection in both populations encode proteins with predomi-
nantly roles surface proteins (e.g. MSPs) and antigens. The majority of the 26 genes identified
Table 1. Regions under directional selective pressure in Thailand *.
Chr Position / Range Max iHS Gene Annotation
1 284000 5.083 PVX_087910 E3 ubiquitin-protein ligase, putative
1 379430 3.511 . .
2 148413 4.319 . Promoter region MRP1
2 158122 3.452 PVX_097025 multidrug resistance-associated protein 1, MRP1
4 576773 4.289 . .
4 629852 3.483 PVX_003770 merozoite surface protein 5 (MSP5)
5 673939 3.566 PVX_089575 trafficking protein particle complex protein, TRAPPC2L
7 778719 3.986 . .
7 1397181 5.829 PVX_086903 Plasmodium exported protein, unknown function
8 766604 3.709 PVX_095055 Rh5 interacting protein, putative (RIPR)
8 921104 3.451 PVX_095235 protein phosphatase inhibitor 2, putative
8 927191 3.489 PVX_095245 hypothetical protein, conserved
8 985454 3.778 PVX_095305 hypothetical protein, conserved
9 107123 6.186 PVX_090925 protein kinase domain containing protein
9 311594 3.590 . .
9 526557 4.115 PVX_091440 hypothetical protein, conserved
10 1222646 5.499 PVX_097715 hypothetical protein
10 1225529 4.109 . .
10 1261650 9.180 . Promotor region MSP3.1
10 1261852 3.982 PVX_097670 merozoite surface protein 3 (MSP3.1)
11 926166 4.034 . .
12 732115 3.531 PVX_082735 thrombospondin-related anonymous protein (TRAP)
12 734223–745860 4.901 PVX_082730 hypothetical protein, conserved
12 746536 4.319 . .
12 751773 5.473 PVX_082710 hypothetical protein
12 752332 3.558 . .
12 765929 6.849 . .
12 766784 6.170 PVX_082675 merozoite surface protein 7 (MSP7)
12 864218 3.561 PVX_082510 hypothetical protein
12 865780 3.930 PVX_082505 CPW-WPC family protein, putative
12 1020235 5.042 . .
12 2475528 4.740 . .
12 2540841 3.633 PVX_118270 serine/threonine protein kinase, putative
12 2622092 3.446 PVX_118345 protein transport protein SEC7, (SEC7)
12 2638874 4.900 . .
12 2671299 3.501 PVX_118380 GTP-binding protein, putative
12 2732268 3.486 PVX_118460 hypothetical protein, conserved
14 3028986 5.168 . .
* |iHS| > 3.
https://doi.org/10.1371/journal.pone.0177134.t001
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in this study have had positive indices of balancing selection in previous studies [37, 38], or
have orthologues in P. falciparum [18].
Population structure and evidence of differing directional selection in
populations
Both a principal component and a neighbourhood joining tree analysis (Fig 2, S4 Fig) revealed
clustering by continent, in keeping with similar P. falciparum analyses [18, 19]. The across
population long-range haplotype method (Rsb implementation) was applied to compare Thai-
land to the South American population, to identify regions potentially under recent directional
selection (Table 4). We detected several loci including at multidrug resistance-associated pro-
tein MRP1 (PVX_097025), and the CCR4-associated factor 1 (CAF1, PVX_123230) located
Table 2. Regions under directional selective pressure in South America *.
Chr Position / Range Max iHS Gene Annotation
1 490369 3.020 PVX_088190 helicase, putative
1 662401 3.050 PVX_093585 SF-assemblin, putative
2 244790–1 5.316 . Promoter region PVX_081315
3 247791 3.813 PVX_000860 hypothetical protein, conserved
3 372679 4.109 PVX_000695 hypothetical protein, conserved
4 574831 3.029 PVX_003830 serine-repeat antigen 5 (SERA)
5 560637 3.649 PVX_089445 RAD protein (Pv-fam-e)
5 1046482 3.358 PVX_090020 hypothetical protein, conserved
6 627960–1 3.605 PVX_111230 hypothetical protein, conserved
7 437942–60 4.773 PVX_099005 cysteine repeat modular protein 1, CRMP1
7 527651 3.182 PVX_099125 pseudouridylate synthase, putative
7 1116251–2 5.712 PVX_099915 RNA-binding protein, putative
7 1214179 6.840 PVX_087145 nucleolar protein Nop52, putative
8 219359 3.180 PVX_094405 hypothetical protein, conserved
9 730034 3.611 PVX_091700 circumsporozoite-related antigen, EXP1
9 751857 3.149 . Promoter region PVX_091715
9 829890 3.161 PVX_091770 calcium-dependent protein kinase 7, CDPK7
9 1042906–7 5.519 PVX_092035 6-phosphofructokinase, putative
9 1136873 3.110 PVX_092160 hypothetical protein, conserved
10 380535 3.108 PVX_080110 G10 protein, putative
10 1063432 3.592 PVX_097895 TBC domain containing protein
10 1257251 3.291 . Promoter region MSP3.2
10 1260441–2 5.201 . 1 Kb from MSP3.2
11 822715 4.026 PVX_114575 transmembrane amino acid transporter protein
11 1973708 6.074 . .
12 955488 3.652 PVX_082400 myosin C, putative
12 1317195 3.435 PVX_116815 hypothetical protein, conserved
13 215135 3.283 PVX_084350 hypothetical protein, conserved
13 611668 5.708 PVX_084755 hypothetical protein, conserved
13 856226–30 4.519 PVX_085030 aspartyl protease, putative
14 1275835 3.114 PVX_123250 aquaporin, putative (AQP2)
14 1665191 3.572 PVX_123685 histone-lysine N-methyltransferase, SET10
14 1875833 4.986 PVX_123890 hypothetical protein, conserved
* |iHS| > 3.
https://doi.org/10.1371/journal.pone.0177134.t002
Genomic variation in Plasmodium vivax malaria reveals regions under selective pressure
PLOS ONE | https://doi.org/10.1371/journal.pone.0177134 May 11, 2017 7 / 15
within 20kb of DHPS (associated with resistance to sulfadoxine [14]). Five non-synonymous
mutations were identified in the DHPS gene (M616T, P553A, P383A, P382R, P382A), with evi-
dence that the P383A has driven toward fixation across all geographical regions. Except for
mutation in codon 616, all the others have been previously reported [39–42]. The DHFR gene,
associated with resistance to pyrimethamine (part of the SP drug combination), exhibited ele-
vated Rsb (>3). Seven non-synonymous mutations were identified, including the previously
described S58R and S117N [42–44] that were fixed across populations, and F57I/L and T61M
[44–46] that were absent from South America (S3 Table). No evidence was observed of a hard
sweep around the MDR1 copy number gene. However, nine non-synonymous SNP mutations
were identified, five of which have been reported previously. These included the fixed alleles
T958M and M908L, F1076L at high frequency across populations, and G698S and S513R
absent from South America [41–44]. There was no evidence of a sweep around the P. vivax
orthologues of the falciparum chloroquine related CRT (pvcrt-o, PVX_087980) or GTP cyclo-
hydrolase I folate pathway (GTPCH, PVX_123830) genes. No common non-synonymous
mutations were identified within the CRT gene, while 7 low frequency non-synonymous SNPs
where identified in the GTPCH locus.
The Rsb analysis also revealed loci associated with the diversity of vectors, including the P28
(PVX_111180) gene expressed in the surface of the ookinete stage during the mosquito part of
the life cycle, pv47 (PVX_083240) and pv48/45 (PVX_083235) involved in the transmission of
the parasite. There are continental-specific pv47 and pv48/45 SNPs (and haplotypes) as previ-
ously found [47, 48], consistent with the presence of different species of mosquito in each the
regions [49], resembling a similar pattern found in P. falciparum [50].
Table 3. Genetic regions under potential balancing selection pressure in South America (SA) and Thailand (T)*.
Chr. Gene Start Gene End Tajima’s D Gene** Annotation Population
1 521978 527387 3.265 PVX_088235 ferlin, putative SA
3 19187 30715 14.166, 7.134 PVX_001080 hypothetical protein, conserved SA, T
4 265018 267216 2.928 PVX_002785 ATP-dependent acyl-CoA synthetase T
4 562755 566374 4.871, 6.085 PVX_003840 serine-repeat antigen 3 (SERA) SA, T
4 567313 571093 4.944 PVX_003835 serine-repeat antigen 1 (SERA) T
4 572172 575852 3.36 PVX_003830 serine-repeat antigen 5 (SERA) T
4 596283 600192 4.224 PVX_003805 serine-repeat antigen (SERA), putative SA
5 1297808 1301010 3.279 PVX_090285 Pvstp1, putative T
5 1345372 1354047 15.907 PVX_090325 reticulocyte binding protein 2c (RBP2c) T
5 1358748 1360820 5.762 PVX_090330 reticulocyte binding protein 2 (PvRBP-2) T
7 1157742 1162997 5.593, 4.124 PVX_099980 merozoite surface protein 1 (MSP1) SA, T
9 6424 7811 4.195 PVX_090835 hypothetical protein T
10 22046 23460 2.925 PVX_079700 hypothetical protein, conserved T
10 65101 69250 2.793 PVX_079750 hypothetical protein, conserved T
10 1187639 1188909 5.206 PVX_097760 60S ribosomal protein L31, RPL31 SA
10 1218512 1221845 2.939,5.585 PVX_097720 merozoite surface protein 3 (MSP3.10) SA, T
10 1272354 1274193 3.869 PVX_097660 4-diphosphocytidyl-2-C-methyl- kinase, IspE SA
10 1306384 1308153 5.991 PVX_097600 hypothetical protein, conserved SA
12 751041 752204 5.578 PVX_082710 hypothetical protein SA
13 37121 59181 3.876 PVX_084160 dynein heavy chain, putative SA
13 128618 131751 4.099 PVX_084260 hypothetical protein, conserved SA
14 3044644 3046339 2.773 PVX_101575 hypothetical protein, conserved T
* Tajima’s D > 2.5
** at least 5 SNPs per gene.
https://doi.org/10.1371/journal.pone.0177134.t003
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Towards molecular barcoding of P. vivax
The development of molecular barcode for P. vivax could ultimately assist with surveillance
and disease control. Previous work [51] has described a 42 SNP barcode to classify geogra-
phically P. vivax across 7 countries. Across the 46 isolates analysed here, we found 3 SNPs in
the barcode to be either non-segregating or not passing quality control filtering. Use of the
remaining 39 SNPs led to imperfect clustering by continent (S4 Table, S5 Fig). Application of
the FST population differentiation metric identified SNPs driving the observed differences
between Thailand, South America and other populations (S5 Table). These SNPs occurred
in drug resistance loci, including MRP1 (PVX_097025),DHPS (PVX_123230) and UBP1
(PVX_081540) (all FST> 0.72), and in close proximity (e.g. PVX_089960within 8kb of DHFR).
Population differentiation due to genetic diversity in drug resistant loci is also observed in P.
falciparum [18,19].
Previous work has proposed the mitochondria and apicoplast organellar genomes as candi-
date regions for a barcode [29]. Genotyping of organellar markers would benefit from greater
copy number and coverage as well as highly conserved sequences [29]. Eight markers across
five apicoplast genes could differentiate Thai and Southeast Asian samples from the other iso-
lates, and two non-genic markers were found to be exclusive to South America (all FST>0.7, S6
Table). No informative mitochondrial markers were identified (all FST<0.7). Further, as the
Fig 2. Population structure analysis based on 219,288 SNPs shows clustering by continent.
https://doi.org/10.1371/journal.pone.0177134.g002
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organelle genomes are known to be highly conserved between Plasmodia species, when com-
paring a set of P. falciparum geographical markers [26] to P. vivax sequences, we found evi-
dence of positions close in the sequence. Two of the samples (ERR020124 and SRR828528)
had a high density of mixed calls in the organellar genomes, in this case, a signature of P. falcip-
arum overlaying onto P. vivax (S6 Fig). In general, this density signature is indicative of a co-
infection of P. vivax with another Plasmodium spp. By comparing the sequencing reads to the
Plasmodium knowlesi reference genome [52], there was no evidence of any vivax and knowlesi
co-infections. However, the presence of a unique triallelic SNP reinforces the potential for an
organellar inter-plasmodia species barcode (S6 Fig).
Table 4. Regions under directional selective pressure between Thailand and South America *.
Chr Position/Range Rsb Gene Annotation
2 145708–151606 11.80 . Promoter region MRP1
2 154067–158122 5.230 PVX_097025 multidrug resistance-associated protein 1, MRP1
2 175191–176803 3.717 PVX_081215 hypothetical protein, conserved
4 91457 5.879 PVX_002550 hypothetical protein, conserved
4 607568–607837 4.457 PVX_003795 serine-repeat antigen (SERA)
4 629831–630120 5.205 PVX_003770 merozoite surface protein 5
5 1132736 10.20 PVX_090105 holo-[acyl-carrier-protein] synthase, putative (ACPS)
5 964771 3.624 PVX_089950 bifunctional dihydrofolate reductase-thymidylate synthase, DHFR-TS
6 199049–199165 4.703 PVX_001850 hypothetical protein
6 605656–608119 3.788 PVX_111260 hypothetical protein, conserved
6 635433–635539 4.406 PVX_111220 RNA helicase, putative
6 661816 6.048 PVX_111180 28 kDa ookinete surface protein, (P28)
7 1396929–1396961 4.708 . Promoter region PVX_086903
7 1397181 4.700 PVX_086903 Plasmodium exported protein, unknown function
8 219359–220251 5.257 PVX_094405 hypothetical protein, conserved
8 1417014–1417038 4.406 PVX_119515 hypothetical protein, conserved
8 1533222 3.214 PVX_119360 hypothetical protein
9 419318–419619 4.971 . Promoter region PVX_091307
9 920056–920166 4.676 PVX_091880 hypothetical protein, conserved
9 1048990 3.304 PVX_092040 geranylgeranyl pyrophosphate synthase (GGPPS)
9 1229833 3.296 PVX_092275 apical membrane antigen 1 (AMA1)
10 1251585–1257251 7.094 . Promoter region MSP3.2
10 1257754–1257815 6.617 PVX_097675 merozoite surface protein 3 (MSP3.2)
11 1517269 3.234 PVX_113775 6-cysteine protein (P12)
11 1223546–1223790 3.816 . Promoter region PVX_114125
11 1383108–1383155 6.010 PVX_113925 hypothetical protein, conserved
12 286960 3.227 PVX_083240 6-cysteine protein (P47)
13 141889–142286 5.680 PVX_084280 hypothetical protein, conserved
13 620154–620261 5.922 . Promoter region PVX_084770
13 731328–792522 5.375 PVX_084860 hypothetical protein, conserved
13 1034635–1034718 4.101 PVX_085235 hypothetical protein
13 1042774 5.406 PVX_085245 hypothetical protein, conserved
13 1553113 4.126 PVX_085835 hypothetical protein, conserved
14 1231525–1231528 6.056 PVX_123205 CCR4-associated factor 1, (CAF1)
14 1429874 3.903 PVX_123415 adrenodoxin-type ferredoxin, putative
* Rsb > 3; genes in bold refer to loci related with mosquito life stages of the parasite or drug-resistance.
https://doi.org/10.1371/journal.pone.0177134.t004
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Discussion
Several studies have previously described the genomic diversity of P. vivax populations using
whole genome data, but with low sample sizes. Recently, two papers using a combined collec-
tion of over 400 isolates from 17 countries described major genomic diversity in Plasmodium
vivax [6, 7]. Here we analysed a complementary collection of 46 high quality isolates spanning
10 countries across 4 continents in order to position them within the context of this new work.
As expected we confirmed that P. vivax genomic diversity is greater compared to P. falciparum,
and even at a relatively low sample size, the samples clustered geographically. We reveal a
wider genomic distance between South American and Southeast Asian continents than ob-
served between P. falciparum African and Southeast Asian populations [6, 18, 19], highlighted
by the greater and more uniform distribution of SNPs with a high FST across the genome. Hot-
spots of selection pressure were identified, including the previously reported MRP1, DHPS
[14] and other putative drug resistance genes, as well as several loci related with the mosquito
stage of the parasite life cycle. The latter observation is consistent with recent work [6,7] and
the presence of different Anopheles species across continents. We identified structural variants,
including extra copies and deletions in the promoter region of the MDR1 gene, a locus associ-
ated with multiple antimalarial drugs [14]. We also confirmed the duplication in the Duffy
binding protein gene (PvDBP) in a Madagascan sample, and detected it in Thai isolates. This
duplication has been found in parasites from several regions in Africa, South America and
Asia [6,37]. Many of these locations are areas where Duffy-negative individuals make up
>45% of the population. However other regions like Cambodia do not present Duffy-negative
individuals [53]. It has been theorized that the duplication allows the parasite to infect Duffy
negative individuals [53], however more research is needed in this area.
Microsatellite genotyping has been used previously to cluster geographically P. vivax iso-
lates, and together with antigen genotyping identify mixed infections and extent of transmis-
sion, used as the basis of genetic epidemiology. In comparison, whole genome sequencing
provides a higher specificity in the application of geographical clustering [51]. While other
studies have focused on creating a barcode using the nuclear genome [51], we also considered
organelle genomes (mitochondrion and apicoplast), which are more stable over time, do not
undergo recombination and are co-inherited [29]. The analysis revealed organellar markers
that are potentially Southeast Asian and South American specific, and others that highlighted
the presence of multi-species mixed infections. The sequencing of large numbers of isolates,
beyond currently published samples sizes, will be required to establish robust intra- and inter-
species organellar-based barcode. Such large-scale datasets across multiple regions will also
serve to identify the high genomic diversity that lies within and between P. vivax populations,
which could be exploited for biological insights, including elucidating drug resistance and
invasion mechanisms, and ultimately measures of disease control.
Conclusion
This study has shown that genomic diversity that lies within and between P. vivax populations
can be used to elucidate potential drug resistance and invasion mechanisms, as well as facilitate
the molecular barcoding of the parasite for surveillance applications.
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